Mild traumatic brain injury often leads to visual dysfunctions, even in patients who do not report vision problems.

Researchers identify how specific features of the retinal vasculature may help predict an individual’s risk of stroke.

The findings suggest that retinal scans could become a valuable tool for assessing stroke risk, especially in primary care ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”, the "Company”), a biopharmaceutical company committed to redefining the ...

In this video from the AAO meeting, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses the role of AREDS vitamins in slowing the progression of geographic atrophy.“That is ...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced ...

How can you create a device that can test Indians’ eyes without dilating them? This was the question K Chandrasekhar (KC) and ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to redefining the retina experience, outlined ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

A vascular 'fingerprint' on the light sensitive tissue layer at the back of the eye—the retina—can predict a person's risk of stroke as accurately as ...